J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.BO)

1.786,30 -17,05 (-0,95%) In data: 03:29PM IST. Mercato aperto.

J. B. Chemicals & Pharmaceuticals Limited

Cnergy IT Park
Unit A2, 3rd floor & Unit A, 8th floor Appa Saheb Marathe Marg Prabhadevi
Mumbai 400025
India
91 22 2439 5200
https://www.jbpharma.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Nikhil Ashokkumar Chopra	CEO & Whole-Time Director	65,45M	N/D	N/D
Mr. Kunal Khanna	President of Operations	N/D	N/D	N/D
Mr. Sridhar Bharadwaj	Vice President of HR & Administration	N/D	N/D	N/D
Mr. Himanshu Ranvah	Vice President of Legal	N/D	N/D	1985
Mr. Pradeep Kumar Singh	President of Global Business	N/D	N/D	1964
Mr. Parmeshwar B. Bang	Executive Vice President of Operations of Daman	N/D	N/D	1968
Mr. Bhushan Sachdeva	Executive Vice President of Supply Chain Operations	N/D	N/D	N/D
Mr. Jason D'Souza	Executive Vice President	N/D	N/D	N/D
Mr. Dilip Singh Rathore	President of India Business	N/D	N/D	1977
Dr. Sujay Rajhans	President of R&D	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in INR.

Descrizione

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. The company provides its services in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

Governance aziendale

L'ISS Governance QualityScore di J. B. Chemicals & Pharmaceuticals Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.